ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
The Relationship Between Urinary Neonicotinoid Concentrations and Obesity Among Individuals Aged 35 to 74 in Guangxi, China.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The increasing worldwide incidence of overweight and obesity poses a significant health concern. The global application of neonicotinoids (NEOs) continues to rise. However, the relationship between NEOs and obesity remains unclear in middle-aged and elderly Chinese individuals. Objective: The purpose of this cross-sectional study was to assess the association between urinary concentrations of NEOs and obesity among individuals aged 35-74 years in Guangxi, China. Methods: In this cross-sectional study, urinary concentrations of 10 NEOs were analyzed in 862 participants. Overweight and obesity (OWO) was defined as body mass index (BMI) ≥24 kg/m Results: Multivariate logistic regression showed that clothianidin (CLO), N-desmethyl-acetamiprid (NACE), and imidacloprid (IMI) were positively associated with Group 4 (with both OWO and ABO). The GLM model revealed a significant positive association between NACE and ABO (OR = 1.177, 95% CI: 1.046, 1.328, Conclusion: Research findings indicated that CLO, NACE, IMI, and NEOs mixture were positively associated with obesity, with CLO and NACE serving as significant factors.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.